Stem Cell Research (May 2020)

Establishment of an induced pluripotent stem cell line from a patient with CHARGE syndrome carrying a CHD7 (p.L1151Gfs*17) mutation

  • Shouhuan He,
  • Jintao Hu,
  • Zhong Zheng,
  • Jingjing Wang,
  • Jianling Chen,
  • Cui Zhang,
  • Liang Li,
  • Jiping Wang,
  • Zhengnong Chen,
  • Haibo Shi,
  • Jinfu Wang

Journal volume & issue
Vol. 45

Abstract

Read online

CHARGE syndrome is a rare disease caused by a genetic disorder. The clinical features of this syndrome include coloboma of the eye, heart anomaly, choanal atresia, retardation of mental and somatic development, microphallus, ear abnormalities and/or deafness. CHD7 is the main causative gene for CHARGE syndrome. In this study, we generated an induced pluripotent stem cell (iPSC) line from the dermal fibroblasts of a 1.5-year-old girl, carrying a de novo mutation (CHD7;NM_017780;c.3449_3450delTC;p.L1151Gfs*17). This iPSC line will be a useful tool for investigating the pathogenesis and for developing treatment for this complicated syndrome.